RADCOM (RDCM) 20-F 29 Mar 22 2021 FY Annual report (foreign) Financial data

Document And Entity Information

Document And Entity Information	12 Months Ended
	Dec. 31, 2021shares
Document Information Line Items
Entity Registrant Name	RADCOM LTD.
Trading Symbol	RDCM
Document Type	20-F
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding	14,155,186
Amendment Flag	false
Entity Central Index Key	0001016838
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Emerging Growth Company	false
Entity Shell Company	false
ICFR Auditor Attestation Flag	true
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	0-29452
Entity Incorporation, State or Country Code	L3
Entity Address, Address Line One	24 Raoul Wallenberg Street
Entity Address, City or Town	Tel-Aviv
Entity Address, Postal Zip Code	69719
Entity Address, Country	IL
Title of 12(b) Security	Ordinary Shares, NIS 0.20 par value per share
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Document Accounting Standard	U.S. GAAP
Auditor Firm ID	1281
Auditor Name	KOST FORER GABBAY & KASIERER
Auditor Location	Tel-Aviv, Israel
Business Contact
Document Information Line Items
Entity Address, Address Line One	24 Raoul Wallenberg Street
Entity Address, City or Town	Tel Aviv
Entity Address, Postal Zip Code	69719
Entity Address, Country	IL
Contact Personnel Name	Ms. Hadar Rahav
City Area Code	(+972)
Local Phone Number	77-774-5060
Contact Personnel Fax Number	(+972) 3-647-4681
Entity Address, Address Line Two	Tel Aviv

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash and cash equivalents	$ 11,948	$ 13,548
Short-term bank deposits	58,621	55,413
Trade receivables, net	10,031	12,446
Inventories	931	540
Other accounts receivable and prepaid expenses	1,964	1,437
Total current assets	83,495	83,384
NON- CURRENT ASSETS:
Severance pay fund	3,840	3,814
Other long-term receivables	1,258	2,185
Property and equipment, net	1,260	1,311
Operating lease right-of-use assets	1,808	2,945
Total non-current assets	8,166	10,255
Total assets	91,661	93,639
CURRENT LIABILITIES:
Trade payables	2,651	1,592
Employees and payroll accruals	4,422	4,414
Deferred revenues and advances from customers	2,700	3,149
Current maturities of lease liabilities	1,045	1,028
Other liabilities and accrued expenses	5,428	4,721
Total current liabilities	16,246	14,904
NON-CURRENT LIABILITIES:
Accrued severance pay	4,335	4,473
Operating lease liabilities	894	2,008
Other liabilities and accrued expenses	32	235
Total non-current liabilities	5,261	6,716
Total liabilities	21,507	21,620
COMMITMENTS AND CONTINGENCIES
Share capital:
Ordinary Shares of NIS 0.20 par value: Authorized: 20,000,000 shares at December 31, 2021 and 2020; 14,191,218 and 13,967,488 shares issued and 14,155,186 and 13,931,456 shares outstanding at December 31, 2021 and 2020, respectively	669	657
Additional paid-in capital	143,473	140,129
Accumulated other comprehensive loss	(2,620)	(2,662)
Accumulated deficit	(71,368)	(66,105)
Total shareholders’ equity	70,154	72,019
Total liabilities and shareholders’ equity	$ 91,661	$ 93,639

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - ₪ / shares	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Ordinary shares, par value (in New Shekels per share)	₪ 0.2	₪ 0.2
Ordinary shares, shares authorized	20,000,000	20,000,000
Ordinary shares, shares issued	14,191,218	13,967,488
Ordinary shares, shares outstanding	14,155,186	13,931,456

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Products	$ 15,336	$ 17,742	$ 16,382
Services	24,946	19,820	16,300
Projects			328
Total revenues	40,282	37,562	33,010
Cost of revenues:
Products	5,543	5,340	4,811
Services	5,880	5,418	5,022
Projects			84
Total cost of revenues	11,423	10,758	9,917
Gross profit	28,859	26,804	23,093
Operating expenses:
Research and development	20,347	19,199	18,578
Less - royalty-bearing participation	537	1,358	1,838
Research and development, net	19,810	17,841	16,740
Sales and marketing	10,358	9,709	10,514
General and administrative	4,184	3,836	3,674
Total operating expenses	34,352	31,386	30,928
Operating loss	(5,493)	(4,582)	(7,835)
Financial income, net	354	810	1,172
Loss before taxes on income	(5,139)	(3,772)	(6,663)
Taxes on income	(124)	(220)	(169)
Net loss	$ (5,263)	$ (3,992)	$ (6,832)
Basic and diluted net loss per Ordinary Share (in Dollars per share)	$ (0.37)	$ (0.29)	$ (0.5)
Weighted average number of Ordinary Share used in computing basic and diluted net loss per Ordinary Share (in Shares)	14,124,404	13,927,788	13,779,885

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net loss	$ (5,263)	$ (3,992)	$ (6,832)
Other comprehensive income (loss):
Foreign currency translation adjustments	42	(28)	(22)
Total other comprehensive loss	42	(28)	(22)
Comprehensive loss	$ (5,221)	$ (4,020)	$ (6,854)

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Share capital amount		Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit	Total
Balance at Dec. 31, 2018	$ 643		$ 135,730	$ (2,612)	$ (55,281)	$ 78,480
Balance (in Shares) at Dec. 31, 2018	13,699,727
Share-based compensation and RSUs			2,228			2,228
Exercise of options into Ordinary Shares		[1]	16			16
Exercise of options into Ordinary Shares (in Shares)	2,250
RSUs vested	$ 5		(5)
RSUs vested (in Shares)	84,176
Net loss					(6,832)	(6,832)
Other comprehensive income/loss				(22)		(22)
Balance at Dec. 31, 2019	$ 648		137,969	(2,634)	(62,113)	73,870
Balance (in Shares) at Dec. 31, 2019	13,786,153
Share-based compensation and RSUs			2,169			2,169
RSUs vested	$ 9		(9)
RSUs vested (in Shares)	145,303
Net loss					(3,992)	(3,992)
Other comprehensive income/loss				(28)		(28)
Balance at Dec. 31, 2020	$ 657		140,129	(2,662)	(66,105)	72,019
Balance (in Shares) at Dec. 31, 2020	13,931,456
Share-based compensation and RSUs			3,356			3,356
RSUs vested	$ 12		(12)
RSUs vested (in Shares)	223,730
Net loss					(5,263)	(5,263)
Other comprehensive income/loss				42		42
Balance at Dec. 31, 2021	$ 669		$ 143,473	$ (2,620)	$ (71,368)	$ 70,154
Balance (in Shares) at Dec. 31, 2021	14,155,186
[1]	Represents an amount lower than $1.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (5,263)	$ (3,992)	$ (6,832)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	540	699	752
Share-based compensation	3,356	2,169	2,228
Change in:
Severance pay, net	(164)	120	81
Trade receivables, net	2,412	(1,653)	9,303
Other account receivables and prepaid expenses	289	114	(1,753)
Inventories	(410)	811	(1,135)
Trade payables	1,017	(773)	998
Employees and payroll accruals	16	314	717
Other liabilities and accrued expenses	724	530	2,694
Deferred revenue and advances from customers	(411)	2,267	562
Net effect of exchange rate differences and other on operating lease right-of-use assets and liabilities	40	(297)	388
Accrued interest on short-term bank deposits	(144)	(359)	(1,163)
Net cash provided by (used in) operating activities	2,002	(50)	6,840
Cash flows from investing activities:
Net proceeds from (investment in) short-term bank deposits	(3,064)	8,026	(61,917)
Purchase of property and equipment	(437)	(427)	(699)
Net cash provided by (used in) investing activities	(3,501)	7,599	(62,616)
Cash flows from financing activities:
Exercise of options into Ordinary Shares			16
Net cash provided by financing activities			16
Foreign currency translation adjustments on cash and cash equivalents	(101)	(202)	(27)
Increase (decrease) in cash and cash equivalents	(1,600)	7,347	(55,787)
Cash and cash equivalents at beginning of the year	13,548	6,201	61,988
Cash and cash equivalents at end of the year	11,948	13,548	6,201
Purchase of property and equipment	55	36	47
Net increase (decrease) in operating lease right-of-use assets	117	(1,492)	1,133
(b) Cash paid during the year for:
Taxes on income	$ 82	$ 128	$ 118

General

General	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
GENERAL	NOTE 1: - GENERAL a. RADCOM Ltd. (the “Company”), an Israeli corporation, is a leading provider of 5G ready cloud-native, network intelligence and service assurance solutions for telecom operators (“CSP”). The Company’s solutions support CSPs in their transition to virtualization and 5G networks, delivering dynamic, on-demand service assurance and network troubleshooting for real time customer and service insights The Company’s solutions include RADCOM Service Assurance, a cloud-native, 5G-ready, fully virtualized service assurance solutions which allows telecom operators to gain end-to-end network visibility and customer experience insights across all networks; RADCOM Network Visibility, a cloud-native network packet broker and filtering solution that allows CSPs to manage network traffic at scale across multiple cloud environments and control the visibility layer to perform dynamic, on-demand analysis of select datasets; and RADCOM Network Insights, a business intelligence solution offering smart insights for multiple use cases, enabled by data captured and correlated through RADCOM Network Visibility and RADCOM Service Assurance. The Company specializes in solutions for next-generation mobile and fixed networks, including 5G, Long Term Evolution (“LTE”), Voice over LTE (“VoLTE”), Voice over Wifi (“VoWifi”), IP Multimedia Subsystem (“IMS”), Voice over IP (“VoIP”), and Universal Mobile Telecommunication Service (“UMTS”). The Company’s shares (the “Ordinary Shares”) are listed on the Nasdaq Capital Market under the symbol “RDCM”. The Company has wholly-owned subsidiaries in the United States and Brazil, that are primarily engaged in the sales, marketing, deployment and customer support of the Company’s products in United States and Brazil. The Company also has a wholly-owned subsidiary in India, that primarily provides customer support and development services worldwide. b. The Company depends on a limited number of customers for selling its solution. Such customers accounted for 88% of the Company’s revenues for the year ended December 31, 2021. If these customers become unable or unwilling to continue to buy the Company’s solution, it could adversely affect the Company’s results of operations and financial position (see also Note 12b). The loss of any major customer, a significant decrease in business from any such customer or a reduction in customer revenue due to adverse changes in the market, economic or competitive conditions or other factors could have a material adverse effect on the Company’s business, results of operations and financial condition.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2: - SIGNIFICANT ACCOUNTING POLICIES The consolidated financial statements are prepared according to United States generally accepted accounting principles (“U.S. GAAP”). a. Use of estimates: The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. b. Financial statements in U.S. dollars (“$” “dollar” or “dollars”): Most of the revenues of the Company and its subsidiaries, other than the Company’s subsidiary in Brazil, are denominated in U.S. dollars. Financing activities are made in U.S. dollars. Therefore, the Company’s management believes that the currency of the primary economic environment in which the operations of the Company and its subsidiaries are conducted is the dollar, which is used as the functional currency. Transactions and balances originally denominated in dollars are presented at their original amounts. Transactions and balances in other currencies are re-measured into dollars in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 830 “Foreign Currency Matters.” Other than in the Company’s subsidiary in Brazil, all exchange gains and losses from Amounts in the financial statements representing the dollar equivalent of balances denominated in other currencies do not necessarily represent their real or economic value and such amounts may not necessarily be exchangeable for dollars. For the Company’s subsidiary in Brazil whose functional currency is the BRL, all amounts on the balance sheets have been translated into the dollar using the exchange rates in effect on the relevant balance sheet dates. All amounts in the statements of operations have been translated into the dollar using the exchange rate on the respective dates on which those elements are recognized. The resulting translation adjustments are reported as a component of accumulated other comprehensive income in shareholders’ equity. c. Principles of consolidation: The consolidated financial statements include the financial statements of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. d. Cash and cash equivalents: The Company considers all highly liquid deposit instruments with an original maturity of three months or less at the date of purchase to be cash equivalents. e. Short-term bank deposits: Short-term bank deposits are deposits with maturities of more than three months but less than one year and which do not meet the definition of cash equivalents . Such deposits include annual interest rates ranging between 0.56%-1.6% resulting in accrued interest of $144 f. Trade receivables: Trade receivables are recorded and carried at the original invoiced amount which was recognized as revenues less an allowance for credit losses. The Company grants credit to customers without generally requiring collateral or security. The Company makes estimates of expected credit losses based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company’s consolidated statements of income (loss). Allowance for credit losses as of December 31, 2020 and 2021, amounted to $5 for both years. g. Concentration of credit risk: Financial instruments that may subject the Company to significant concentration of credit risk consist mainly of cash and cash equivalents, short-term bank deposits, severance pay fund and trade receivables. Cash and cash equivalents are maintained with major financial institutions mainly in Israel. Assets held for severance benefits are maintained with major insurance companies and financial institutions in Israel. Such deposits are not insured. However, management believes that such financial institutions are financially sound and, accordingly, low credit risk exists with respect to these investments. h. Inventories: Inventories are stated at the lower of cost and net realizable value. The cost of inventories comprises costs of purchase and costs incurred in bringing the inventories to their present location and condition. Inventory write-offs are provided to cover technological obsolescence, excess inventories and discontinued products. Inventory write-off is measured as the difference between the cost of the inventory and net realizable value based upon assumptions about future demand and is charged to the cost of revenues. At the point of the loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. The total inventory write-offs during the year ended December 31, 2020 amounted to $14. No inventory write-offs were recorded during the years ended December 31, 2021 and 2019. i. Property and equipment: Property and equipment are stated at cost less accumulated depreciation. Maintenance and repairs are charged to operations as incurred. Depreciation is calculated on the straight-line method over the estimated useful lives of the assets. Annual rates of depreciation are as follows: % Computers and electronic equipment 15 - 33 Office furniture and equipment 6 - 20 Leasehold improvements At the shorter of the lease period or useful life of the leasehold improvement j. Impairment of long-lived assets: The Company’s long-lived assets are reviewed for impairment in accordance with ASC 360, “Property, plants and equipment”, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of an asset to be held and used is assessed by a comparison of the carrying amount of the asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds its fair value. During the years ended December 31, 2021, 2020 and 2019, no impairment losses were identified. k. Leases Under ASC 842, “Leases” (“ASC 842”), the Company determines if an arrangement is a lease at inception. The Company’s assessment is based on: (1) whether the contract includes an identified asset, (2) whether the Company obtains substantially all of the economic benefits from the use of the asset throughout the period of use, and (3) whether the Company has the right to direct how and for what purpose the identified asset is used throughout the period. The Company elected the package of practical expedients permitted under the standard related to treating lease and non-lease components as a single lease component for all equipment leases as well as electing a policy exclusion permitting leases with an original lease term of less than one year to be excluded from the operating lease right-of-use (“ROU”) assets and operating lease liabilities. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and operating lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company consider only payments that are fixed and determinable at the time of commencement. The Company uses its incremental borrowing rate based on the information available at the commencement date to determine the present value of the lease payments. Several of the Company’s leases include options to extend the lease and some have termination options that are factored into the Company’s determination of the lease payments when appropriate. For purposes of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. The Company’s lease agreements do not contain any material residual value guarantees. Operating lease expenses are recognized on a straight-line basis over the lease term. For all short-term leases which are less than 12 months and existing short-term leases of those assets in transition, the Company does not recognize operating lease ROU assets or operating lease liabilities, but recognizes lease expenses over the lease term on a straight-line basis. See Note 9 for further information on leases. l. Revenue recognition: The Company’s solution is sold to customers directly, through resellers and to lesser extent through distributors. Sales through resellers are considered final sales per revenue recognition criteria. The Company recognizes revenues in accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation as follows: a) Identify the contract with a customer: b) Identify the performance obligations in the contract: c) Determine the transaction price: Generally, the Company doesn’t grant its customers a right to return the products sold. However, in some cases, the arrangements may include refunds, liquidated damages, penalties or other damages if the Company fails to deliver future goods or services or if the goods or services fail to meet certain specifications to acceptance criteria. All of the above are accounted for as variable considerations, which may result in an adjustment to the transaction price. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company’s estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available. The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is a year or less. As the period of time between delivery and payment for most of the Company's contracts is less than one year, these contracts are not assessed for a significant financing component. In other contracts, the Company determined that those contracts generally do not include a significant financing component, as the primary purpose of the invoicing terms for these contracts is to provide customers with simplified and predictable ways of purchasing the Company's products and services, not to receive or provide financing. d) Allocate the transaction price to the performance obligations in the contract: The Company’s selling price is highly variable. e) Recognize revenue when a performance obligation is satisfied: Products Services: Projects: Deferred revenues represent unrecognized fees collected as well as other advances and payments received from customers, for which revenue has not yet been recognized. Deferred revenues are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized. See also Note 3 for additional revenue recognition disclosures. m. Cost of revenues: Cost of revenues is comprised of cost of third-party hardware and software license fees, maintenance fees related to such third-party hardware and software, employees’ salaries and related costs, shipping and handling costs, subcontractors, inventory write-offs, indirect taxes, importation taxes and royalties to the Israel Innovation Authority (the “IIA”). n. Share-based compensation: The Company accounts for share-based compensation in accordance with ASC 718, “Compensation — Stock Compensation”, which requires companies to estimate the fair value of share-based payment awards on the grant date using an option-pricing model. The Company recognizes compensation expenses for the value of its awards over the requisite service period of each of the awards. For graded vesting awards subject to service conditions only, the Company uses the straight-line attribution method. The Company estimates expected forfeitures. The Company selected the Black-Scholes option-pricing model as the most appropriate fair value method for its share-options awards. The option-pricing model requires a number of assumptions, of which the most significant are the expected share price volatility and the expected option term. Expected volatility was calculated based upon actual historical share price movements over the most recent periods ending on the grant date, equal to the expected option term. The expected term was generated by running the Monte Carlo model pursuant to which historical post-vesting forfeitures and suboptimal exercise factor are estimated by using historical option exercise information. The suboptimal exercise factor is the ratio by which the share price must increase over the exercise price before employees are expected to exercise their share options. The expected term of the options granted is derived from the output of the options valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on the yield from U.S. Treasury zero-coupon bonds with an equivalent term to the expected term of the options. Historically the Company has not paid dividends and in addition has no foreseeable plans to pay dividends, and therefore uses an expected dividend yield of zero in the option-pricing model No options were granted in 2021 and 2019. The fair value for options granted in 2020 is estimated at the date of grant with the following weighted average assumptions: 2020 Dividend yield 0% Expected exercise factor 2.67 Expected volatility 41.92%-45.21% Risk-free interest 0.25%-0.27% Expected life (in years) 4.32-4.75 Change in Accounting Principle - Share-based Compensation In 2021, the Company elected to change its accounting policy for recognizing share-based compensation expense for graded vesting share awards subject to service conditions only by applying the straight-line attribution method instead of the accelerated attribution method and using an estimated forfeiture rate of awards expected to be forfeited for each award rather than account for the forfeitures as they occur. The change in the recognition of share-based compensation expense represents a change in accounting principle which the Company believes to be preferable because the straight-line attribution method is the predominant method used in its industry and because estimating forfeitures will result in a more accurate attribution of share-based compensation expense since the Company has accumulated during the last few years sufficient historical experience to make a reasonable estimate of the forfeiture pattern of its employees. A change in accounting principle requires retrospective application, if material. The impact of the change in the accounting policy described above to the Company's time-based awards was immaterial to prior periods and to the year ended December 31, 2021. As a result, the Company has accounted for the cumulative effect of this change in its consolidated results for the year ended December 31, 2021. The effect of the new policy was a decrease in net loss of $141, or $0.01 per share (basic and diluted), for the year ended December 31, 2021. o. Research and development costs: Research and development costs are charged to the statement of operations as incurred except for royalty-bearing participation from the IIA as described in Note 2p. ASC 985-20, “Software - Costs of Computer Software to be Sold, Leased or Otherwise Marketed”, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company’s product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release have been insignificant. Therefore, all research and development costs have been expensed. p. Government grants: The Company receives royalty-bearing grants, which represent participation of the IIA in approved programs for research and development. These amounts are recognized on the accrual basis as a reduction of research and development costs as such costs are incurred. Royalties to the IIA are recorded under cost of revenues, when the related sales are recognized (see also Note 8a1). During the years 2012 to 2017, the Company also received grants from the Israeli Ministry of Economy (the “MOE”), up to 50% of relevant marketing expenses. These grants were presented as a reduction of marketing expenses (see also Note 8a2). q. Income (loss Basic and diluted income (loss) per Ordinary Share is presented in conformity with ASC 260, “Earnings Per Share”, for all years presented. Basic income (loss) per Ordinary Share is computed by dividing net income (loss) for each reporting period by the weighted average number of Ordinary Shares outstanding during the period. Diluted income (loss) per Ordinary Share is computed by dividing net income (loss) for each reporting period by the weighted average number of Ordinary Shares outstanding during the period plus any additional Ordinary Shares that would have been outstanding if potentially dilutive securities had been exercised during the period, calculated under the treasury stock method. Certain securities were not included in the computation of diluted income (loss) per share since they were anti-dilutive. The total weighted average number of shares related to the outstanding options and restricted share units (“RSUs”) excluded from the calculation of diluted net income (loss) per share was, 956,356, 877,195 and 802,159 for the years ended December 31, 2021, 2020 and 2019, respectively. r. Income taxes: The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". Deferred tax asset and liability account balances are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statement of operations in the period that includes the enactment date. Deferred tax assets and liabilities are classified as noncurrent on the balance sheet. The Company provides a full valuation allowance to reduce deferred tax assets to the extent it believes it is more likely than not that such benefits will be realized. s. Income tax uncertainties: In accordance with ASC 740, the Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% of the amount likely to be realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. When applicable, the Company accounts for interest and penalties related to unrecognized tax benefits as a component of income tax expense. As of December 31, 2021 and 2020, no liability for unrecognized tax benefits was recorded. t. Severance pay: The Company’s liability for severance pay is recorded mainly with respect to its Israeli employees and is calculated pursuant to Israeli severance pay law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. After completing one full year of employment, the Company’s Israeli employees are entitled to one month’s salary for each year of employment or a portion thereof. The Company’s liability is partially provided by monthly deposits with severance pay funds, insurance policies and by an accrual. The liability for employee severance pay benefits included on the balance sheet represents the total liability for such severance benefits, while the assets held for severance benefits included on the balance sheet represent the current redemption value of the Company’s contributions made to severance pay funds and to insurance policies. The carrying value of deposited funds includes profits (losses) accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements. Effective January 1, 2012, the Company’s agreements with new employees in Israel are in accordance with section 14 of the Severance Pay Law – 1963, which provides that the Company’s contributions to the severance pay fund shall cover its entire severance obligation. Upon termination, the release of the contributed amounts from the fund to the employee shall relieve the Company from any further severance obligation and no additional payments shall be made by the Company to the employee. As a result, the related obligation and amounts deposited on behalf of such obligation are not recorded as part of the balance sheet, as the Company is legally released from its severance obligation to employees once the amounts have been deposited, and the Company has no further legal ownership of the amounts deposited. Severance expenses for the years ended December 31, 2021, 2020 and 2019 amounted to $922, $1,195, and $1,150, respectively. u. Fair value of financial instruments: The Company follows the provisions of ASC No. 820, “Fair Value Measurement”, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining a fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing an asset or liability, based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect assumptions that market participants would use in pricing an asset or liability, based on the best information available under given circumstances. The hierarchy is broken down into three levels, based on the observability of inputs and assumptions, as follows: Level 1 - Observable inputs obtained from independent sources, such as quoted prices for identical assets and liabilities in active markets. Level 2 - Other inputs that are directly or indirectly observable in the marketplace. Level 3 - Unobservable inputs which are supported by little or no market activity. The financial instruments of the Company consist mainly of cash and cash equivalents, short-term bank deposits, trade receivables, trade payables and other liabilities and accrued expenses. The fair values of the Company cash and cash equivalents, account receivables, and account payables approximate their carrying amounts due to their short-term nature. v. Legal contingencies: From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. The Company’s estimations and related accruals if any are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events relating to a particular matter. w. Comprehensive income (loss): The Company accounts for comprehensive income (loss) in accordance with ASC 220, “Comprehensive Income”, which establishes standards for the reporting and displays of comprehensive income and its components in a full set of general-purpose financial statements. Comprehensive income generally represents all changes in shareholders’ equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its only item of other comprehensive income relates to foreign currency translation adjustment and gains or losses on intercompany foreign currency transactions that are of a long-term investment nature in connection with its subsidiary in Brazil. x. Recently issued and adopted accounting standards: In December 2019, the FASB issued Accounting Standards Update (“ASU”) No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2020-12”), which simplifies the accounting for income taxes. ASU 2019-12 is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2020. The adoption of this standard did not have a material effect on the Company’s consolidated financial statements. y. Recently issued accounting standards: In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832): Disclosure by Business Entities about Government Assistance (ASU 2021-10), which improves the transparency of government assistance received by most business entities by requiring the disclosure of: (1) the types of government assistance received; (2) the accounting for such assistance; and (3) the effect of the assistance on a business entity's financial statements. This guidance is effective for financial statements issued for annual periods beginning after December 15, 2021. Early adoption is permitted. The Company will adopt this standard on January 1, 2022. The Company does not expect that the adoption of this standard will result in a material impact on the Company's consolidated financial statements.

Revenues

Revenues	12 Months Ended
	Dec. 31, 2021
Revenues Disclosure [Abstract]
REVENUES	NOTE 3: - REVENUES Revenue is recognized when or as performance obligations are satisfied by transferring control of a promised good or service to a customer. Control is either transferred over time or at a point in time, which affects the revenue recognition schedule. Costs to obtain contracts The Company capitalizes an asset for the incremental costs of obtaining a contract whenever such expenses are expected to be recovered. Capitalized costs derive primarily from sales commissions or incentives granted to employees and partners. The Company’s contracts with customers include performance obligations related to products and services, some of which are satisfied at a point in time and others over time. Commission costs related to performance obligations satisfied at a point in time are expensed at the time of sale, which is when revenue is recognized. Commission costs related to long-term service contracts and performance obligations satisfied over time are deferred and recognized on a systematic basis that is consistent with the transfer of the products or services to which the asset relates. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income (loss). Deferred commission costs capitalized are periodically reviewed for impairment. As of December 31, 2021 and 2020, the deferred commission costs capitalized included within other long-term receivables in the consolidated balance sheets were $1,052 and $1,994, respectively. During the year ended December 31, 2021, the Company recorded new contract acquisition assets in the amount of $248 and amortized $1,190 of capitalized contract acquisition costs into sales and marketing expense. No impairment losses were recognized during such period. Contract balances The Company receives payments from customers based upon contractual payment schedules. Trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables include amounts related to the Company’s contractual right to consideration for completed performance obligations not yet invoiced. As of December 31, 2021 and 2020, unbilled receivables balances amounted to $1,457 and $2,570, respectively and are included within trade receivables balance in the Company’s balance sheets. As of December 31, 2021, the Company had $39,927 of remaining performance obligations not yet satisfied or partly satisfied related to revenues. The Company expects to recognize approximately 67% of this amount as revenues during the next 12 months and the rest thereafter. During the year ended December 31, 2021, the Company recognized $2,333 that was included in deferred revenues (short-term contract liability) balance on January 1, 2021. For disaggregation of revenues please see Note 12b.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
INVENTORIES	NOTE 4: - INVENTORIES December 31, 2021 2020 Finished products (*) $ 931 $ 540 (*) Includes amounts of $570 and $399 as of December 31, 2021 and 2020, respectively, with respect to inventory delivered to customers for which control has not been transferred.

Other Accounts Receivable and P

Other Accounts Receivable and Prepaid Expenses	12 Months Ended
	Dec. 31, 2021
Prepaid Expense and Other Assets [Abstract]
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES	NOTE 5: - OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES December 31, 2021 2020 Governmental authorities $ 340 $ 252 Prepaid expenses 1,593 1,135 Others 31 50 $ 1,964 $ 1,437

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	NOTE 6: - PROPERTY AND EQUIPMENT, NET Composition of assets, grouped by major classification, is as follows: December 31, 2021 2020 Cost: Computers and electronic equipment $ 4,235 $ 3,806 Office furniture and equipment 404 392 Leasehold improvements 297 277 4,936 4,475 Accumulated depreciation: Computers and electronic equipment 3,399 2,945 Office furniture and equipment 179 151 Leasehold improvements 98 68 3,676 3,164 $ 1,260 $ 1,311 Depreciation expenses for the years ended December 31, 2021, 2020 and 2019 amounted to $540, $699 and $752, respectively.

Other Current Liabilities and A

Other Current Liabilities and Accrued Expenses	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
OTHER CURRENT LIABILITIES AND ACCRUED EXPENSES	NOTE 7: - OTHER CURRENT LIABILITIES AND ACCRUED EXPENSES December 31, 2021 2020 Royalties - IIA payable $ 1,026 $ 986 Accrued commissions 1,040 2,018 Accrued expenses 3,362 1,717 $ 5,428 $ 4,721

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8: - COMMITMENTS AND CONTINGENCIES a. Royalty commitments: 1. The Company receives research and development grants from the IIA. In consideration for the research and development grants received from the IIA, the Company has undertaken to pay royalties as a percentage of revenues from products developed from research and development projects financed. If the Company does not generate sales of products developed with funds provided by the IIA, the Company is not obligated to pay royalties or repay the grants. Royalties are payable at the rate of 3% from the time of commencement of sales of all of the Company’s products until the cumulative amount of the royalties paid equals 100% of the dollar-linked amounts of the grants received, plus interest at LIBOR. As of December 31, 2021, the Company’s total commitment with respect to royalty-bearing participation received or accrued, net of royalties paid or accrued, amounted to $53,288. The total research and development grants that the Company has received from the IIA as of December 31, 2021 were $48,403. The accumulated interest as of December 31, 2021, was $23,489 and the accumulated royalties paid to the IIA were $18,604. Royalty expenses relating to the IIA grants included in cost of revenues during the years ended December 31, 2021, 2020 and 2019 were $1,209, $1,127, and $990, respectively. In May 2010, the Company received a notice from the IIA regarding alleged miscalculations of the amount of royalties paid by the Company to the IIA for the years 1992-2009 and the revenues basis on which the Company had to pay royalties. The Company believes that all royalties due to the IIA from the sale of products developed with funding provided by the IIA during such years were properly paid or were otherwise accrued. During 2011, the Company reviewed with the IIA the alleged miscalculations. The Company assessed the merits of the aforesaid arguments raised by the IIA and recorded a liability for an estimated loss. 2. In April 2012 and in April 2014, the MOE approved the Company’s application for participation in funding the setting up of the Company’s India subsidiary and China branch as part of a designated grants plan for setting up and establishing a marketing agency in India and China. The grant was intended to cover up to 50% from the costs of the office establishment, logistics expenses and hiring employees and consultants in India and China, based on the approved budget for the plan over a period of three years. The Company is currently in the process of winding down its operations at the China office. The total marketing grants received by the Company from the MOE during the years 2012 to 2017 were in the amount of $668. No further grants are expected to be received from such plans. The Company is obligated to pay to the MOE royalties of 3% on the increased sales in the target market, with respect to the year during which the grant was approved over a period of five years, but not more than the total linked amount of the grant received. No royalties were paid to the MOE during the years ended December 31, 2019, 2020 and 2021. 3. According to the Company’s agreements with the Israel-U.S Bi-National Industrial Research and Development Foundation (“BIRD-F”), the Company is required to pay royalties at a rate of 5% of sales of products developed with funds provided by the BIRD-F, up to an amount equal to 150% of the BIRD-F’s grant, linked to the United States CPI relating to such products. The last funds from the BIRD-F were received in 1996. In the event the Company does not generate sales of products developed with funds provided by the BIRD-F, the Company is not obligated to pay royalties or repay the grants. The total research and development funds that the Company has received from the BIRD-F were $340 (CPI linked amount of $627). According to the above, as of December 31, 2021, the total royaltyies commitment the Company may be required to pay is an amount of up to $941 out of which $518 was paid by the Company in previous years. The remaining commitment with respect to royalty-bearing participation received, net of royalties paid or accrued, amounted to $423 as of December 31, 2021. Since 2003, the Company has not generated sales of products developed with the funds provided by the BIRD-F. Therefore, the Company has not been obligated to pay royalties or repay the grant since such date. b. Bank guarantee: As of December 31, 2021, the Company issued a bank guarantee to the Israeli Customs Authority that amounted to $40, which will expire on April 30, 2022.

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Disclosure Text Block [Abstract]
LEASES	NOTE 9: - LEASES The Company has entered into various operating lease agreements for certain of its offices and car leases with original lease periods expiring between 2021 and 2028. Most of the lease agreements include one or more options to renew. The Company does not assume renewals in determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement. In December 2020, the Company’s lease of its offices in Israel was amended. The amendment included a decrease in rental space and price per meter, as a result of the amendment, the operating lease right of use decreased by $1,717 and the operating lease liability decreased by $2,233, the Company recorded a foreign currency exchange gain of $484 and a termination gain within operating income of $32. Lease payments included in the measurement of the operating lease liability comprise the following: the fixed non-cancelable lease payments and payments for optional renewal periods where it is reasonably certain the renewal period will be exercised. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. As of December 31, 2021, the Company’s assessment for the remaining lease term range between 0.9 years to 6.3 years, including options to extend part of the lease agreements for an additional 2 years and up to 5 years. The following table represents the weighted-average remaining lease term and discount rate: December 31, December 31, 2021 2020 Weighted average remaining lease term 1.84 years 2.20 years Weighted average discount rate 4.92 % 4.46 % The components of lease expense for the year ended December 31, 2021 were as follows: Year ended Year ended December 31, 2021 December 31, 2020 Operating lease $ 1,173 $ 1,223 Short-term lease 5 6 Total lease expense $ 1,178 $ 1,229 Cash paid for amounts included in the measurement of operating lease liabilities was $1,125 and $1,184 during the years ended December 31, 2021 and 2020, respectively. The following is a schedule, by years, of maturities of lease liabilities as of December 31, 2021: Operating Leases 2022 1,014 2023 340 2024 208 2025 129 2026 and thereafter 302 Total operating lease payments $ 1,993 Less: imputed interest 54 Present value of lease liabilities $ 1,939

Taxes on Income

Taxes on Income	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
TAXES ON INCOME	NOTE 10: - TAXES ON INCOME a. Israeli taxation: Taxable income of the Company is subject to the Israeli corporate tax at the rate of 23% for all years presented. Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (“the Law”): In August 2013, the Law for Changing National Priorities (Legislative Amendments for Achieving Budget Targets for 2013 and 2014), 2013 which includes Amendment 71 to the Law (“Amendment 71”) was enacted. Per Amendment 71, the tax rate on preferred income from a preferred enterprise in 2014-2016 will be 9% in certain areas in Israel (“Development Area A”) and 16% in other areas. In 2017, the tax rate at Development Area A was reduced to 7.5%. The Company may claim the tax benefits offered by Amendment 71 in its tax returns, provided that its facilities meet the criteria for tax benefits set out by Amendment 71. A company is also granted a right to approach the Israeli Tax Authorities for a pre-ruling regarding its eligibility for benefits under Amendment 71 (and in some cases is required to apply for such approval). In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law (“Amendment 73”) was published. Amendment 73, which came into effect in January 2017, prescribes special tax tracks for technological enterprises, granting such enterprises a tax rate of 7.5% (in Development Area A) and 12% (in other areas). Under Amendment 73, any dividends distributed to “foreign companies”, as defined in such law, by companies having over 90% foreign (i.e., non-Israeli) ownership, deriving from income from the technological enterprises will be subject to tax at a rate of 4%. In order to comply with the new track determined in Amendment 73, a company must meet certain criteria defined within law (among others R&D expenses and employees at a certain rate). The Company has yet to claim the above-mentioned tax benefits offered and accordingly such reduced taxes were not considered in the computation of the deferred taxes and valuation allowance as of December 31, 2021. In accordance with the tax laws, tax returns submitted up to and including the 2016 tax year can be regarded as final. As of December 31, 2021, no final tax assessments have been received for such years. Tax loss carryforward: As of December 31, 2021, the Company’s estimated tax loss carryforward and capital loss were $38,362 and $1,283, respectively. Such losses can be carried forward indefinitely to offset any future taxable income of the Company. The Company’s research and development expenses carryforward for tax purposes in Israel amounted to approximately $14,029. b. Foreign subsidiaries: U.S. subsidiary: 1. The U.S. subsidiary is taxed under United States federal and state tax rules. Income tax is calculated based on a U.S. federal tax rate of 21%. On December 22, 2017, the Tax Cuts and Jobs Act of 2017 was signed into law making significant changes to U.S. income tax law. Changes include, but are not limited to, a U.S. federal corporate tax rate decrease from 35% to 21% effective for tax years beginning after December 31, 2017, the transition of U.S. international taxation from a worldwide tax system to a territorial system, and a one-time transition tax on the mandatory deemed repatriation of cumulative foreign earnings as of December 31, 2017. 2. The U.S. subsidiary’s estimated federal tax loss carryforward amounted to $2,328 3. The U.S. subsidiary has not received final tax assessments since incorporation. In accordance with the tax laws, tax returns submitted up to and including the 2016 tax year can be regarded as final. Brazilian subsidiary: 1. The Brazilian subsidiary is taxed under Brazilian tax rules. Income tax is calculated based on a 34% rate. 2. The Brazilian subsidiary’s tax loss carryforward amounted to $2,740 as of December 31, 2021, for tax purposes. Tax losses may be carried forward indefinitely but can only be offset up to 30% of the subsidiary’s taxable income for a tax period. 3. The Brazilian subsidiary has not received final tax assessments since incorporation. In accordance with the tax laws, tax returns submitted up to and including the 2016 tax year can be regarded as final. Indian subsidiary: 1. The Indian subsidiary is taxed under Indian tax rules. Income tax is calculated based on a 25% rate. 2. The Indian subsidiary has not received final tax assessments since incorporation. In accordance with the tax laws, tax returns submitted up to and including the 2018 tax year can be regarded as final. c. Deferred taxes: Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and for tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows: December 31 2021 2020 Deferred tax assets: Carryforward tax losses $ 10,540 $ 10,391 Research and development 3,227 2,862 Accrued social benefits and other 505 567 14,272 13,820 Less - valuation allowance (14,272 ) (13,820 ) Net deferred tax assets $ - $ - The net change in the total valuation allowance for the year ended December 31, 2021 was an increase of $452. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets depends on the generation of future taxable income during the periods in which those temporary differences and tax loss carryforward are deductible. Management considers the projected taxable income and tax-planning strategies in making this assessment. In consideration of the Company’s accumulated losses and the uncertainty of its ability to utilize its deferred tax assets in the future, management currently believes that it is more likely than not that the Company will not realize its deferred tax assets and accordingly recorded a valuation allowance to fully offset all the deferred tax assets. d. Taxes on income are mainly comprised from state tax accrual with regards to the U.S. subsidiary, withholding taxes that were deducted by the Company’s customers as well as tax expenses of the Indian subsidiary. e. The components of income (loss) before income taxes are as follows: Year ended December 31, 2021 2020 2019 Domestic $ (6,030 ) $ (4,271 ) $ (7,107 ) Foreign 891 499 444 Loss before income taxes $ (5,139 ) $ (3,772 ) $ (6,663 ) f. Reconciliation of the theoretical tax benefit and the actual tax expense: Year ended December 31, 2021 2020 2019 Loss before income taxes, as reported in the statements of operations $ (5,139 ) $ (3,772 ) $ (6,663 ) Statutory tax rate in Israel 23 % 23 % 23 % Theoretical tax benefit $ (1,182 ) $ (868 ) $ (1,532 ) Increase (decrease) in income taxes resulting from: Tax rate differential on foreign subsidiaries (31 ) (50 ) 12 Non-deductible expenses and other permanent differences 631 393 473 Differences in taxes arising from foreign currency exchange, net 69 257 42 Changes in carry forward tax losses and other temporary differences for which valuation allowance was provided 481 310 910 Other 156 178 264 Income taxes $ 124 $ 220 $ 169 g. Accounting for uncertainty in income taxes: For the years ended December 31, 2021, 2020 and 2019 the Company did not have any unrecognized tax benefits and no interest and penalties related to unrecognized tax benefits have been accrued. The Company does not expect that its position related to unrecognized tax benefits will change significantly within the next 12 months.

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2021
Shareholders’ Equity Text Block [Abstract]
SHAREHOLDERS’ EQUITY	NOTE 11: - SHAREHOLDERS’ EQUITY a. The number of Ordinary Shares outstanding at December 31, 2021, and 2020 does not include 5,189 Ordinary Shares issued, which are held by a subsidiary, and 30,843 Ordinary Shares issued which are held by the Company. Ordinary Shares confer all rights to their holders, e.g. voting, equity and receipt of dividends. b. Share option plan: 1. The Company has granted options under an option plan as follows: a) The 2013 Share Option Plan: On April 3, 2013, the Company approved a new share option plan (the “2013 Share Option Plan”). The 2013 Share Option Plan provides for the grant of options to purchase Ordinary Shares to provide incentives to employees, directors, consultants and contractors of the Company. In accordance with Section 102 of the Income Tax Ordinance (New Version) - 1961, the Company’s Board of Directors (the “Board”) elected the “Capital Gains Route”. On February 19, 2015, the Board adopted an amendment to the 2013 Share Option Plan pursuant to which the Company may grant options to purchase its Ordinary Shares and RSUs to its employees, directors, consultants and contractors. The 2013 Share Option Plan expires on April 2, 2023. b) During the year ended December 31, 2019, the Company’s Board approved the grant of 388,020 RSUs to certain employees and officers of the Company. Such RSUs have vesting schedules of four years, commencing as of the date of grant. c) During the year ended December 31, 2020, the Company’s Board approved the grant of 340,000 RSUs and 35,100 options to certain employees, officers and directors of the Company. Such Options and RSUs have vesting schedules of 2-4 years, commencing as of the date of grant. d) During the year ended December 31, 2021, the Company’s Board approved the grant of 782,350 RSUs to certain employees and officers of the Company. Such RSUs have vesting schedules of 2-4 years, commencing as of the date of grant. As of December 31, 2021, the total number of shares reserved under the 2013 Share Option Plan, is 3,950,000, out of which 1,544,676 Ordinary Shares are still available for future grants under the 2013 Share Option Plan as of that date. 2. Stock options for the year ended December 31, 2021 under the Company’s plans are as follows: Number of Weighted Weighted (in years) Aggregate Outstanding as of January 1, 2021 305,839 14.21 1.33 98 Granted - - Exercised - - Expired and forfeited (166,159 ) 12.40 Outstanding as of December 31, 2021 139,680 16.36 1.20 181 Vested and expected to vest at December 31, 2021 139,680 16.36 1.20 181 Exercisable as of December 31, 2021 121,155 17.70 0.85 85 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of the Company’s Ordinary Shares on the last day of fiscal 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2021. This amount is impacted by the changes in the fair market value of the Company’s Ordinary Shares. 3. As of December 31, 2021, stock options under the 2013 Share Option Plan are as follows: Options outstanding at December 31, 2021 Options exercisable at December 31, 2021 Exercise price Number outstanding Weighted average exercise price Weighted average remaining contractual life Number exercisable Weighted average exercise price Weighted average remaining contractual life $ $ In years $ In years 7.60 35,100 7.60 3.52 16,575 7.60 3.53 18.90 60,002 18.90 0.10 60,002 18.90 0.10 19.85 44,578 19.85 0.87 44,578 19.85 0.87 139,680 121,155 4. RSUs for the year ended December 31, 2021 under the Company’s 2013 Share Option Plan are as follows: Number of Weighted (in years) Aggregate Outstanding as of January 1, 2021 551,175 1.51 $ 5,732 Granted 782,350 Vested (223,730 ) Cancelled (60,866 ) Outstanding as of December 31, 2021 1,048,929 1.54 $ 13,689 5. The weighted average fair value of options granted during the year ended December 31, 2020 was $ 3.41 per share 6. The weighted average fair values of RSUs granted during the years ended December 31, 2021, 2020 and 2019 were $11.36, $9.31 and $7.86 per share, respectively. 7. The following table summarizes the allocation of the Company’s share-based compensation within the statements of operations: Year ended December 31, 2021 (*) 2020 (*) 2019 (*) Cost of revenues $ 207 $ 106 $ 204 Research and development, net 1,368 879 729 Sales and marketing 865 536 638 General and administrative 916 648 657 $ 3,356 $ 2,169 $ 2,228 (*) Including $3,271, $2,107 and $1,887 of compensation cost related to RSUs for the years ended December 31, 2021, 2020 and 2019, respectively. 8. As of December 31, 2021, there are $6,749 of total unrecognized costs related to non-vested share-based compensation and RSUs that are expected to be recognized over a weighted average period of 1.00 years.

Selected Statements of Operatio

Selected Statements of Operations Data	12 Months Ended
	Dec. 31, 2021
Selected Statements of Operations Data [Abstract]
SELECTED STATEMENTS OF OPERATIONS DATA	NOTE 12: - SELECTED STATEMENTS OF OPERATIONS DATA a. The Company applies ASC 280, “Segment Reporting”. The Company operates in one reportable segment (see also Note 1 for a brief description of the Company’s business). b. The following tables present total revenues for the years ended December 31, 2021, 2020 and 2019 and long lived assets, net as of December 31, 2021 and 2020 by geographic regions: 1. Revenues by geographic region are as follows: Year ended December 31, 2021 2020 2019 North America $ 21,777 $ 20,323 $ 14,500 Asia* 14,686 15,190 14,146 Latin America 1,071 223 2,653 EMEA (including Israel) 2,748 1,826 1,711 $ 40,282 $ 37,562 $ 33,010 (*) Includes Japan and the Philippines which accounted for more than 10% of Company’s revenues in all years presented. Total revenues are attributed to geographic areas are based on the location of the end-customer. In 2021, 2020 and 2019, the amount of export revenues represented 94%, 96% and 96%, respectively, of the Company’s total revenues. 2. Major customer data as a percentage of total revenues: Year ended December 31, 2021 2020 2019 A 52 53 41 B 26 29 22 C 10 11 20 88 % 93 % 83 % 3. Long-lived assets by geographic areas: Year ended December 31, 2021 2020 Israel $ 1,730 $ 2,633 United States 885 1,049 Other 453 574 Total long-lived assets (1) $ 3,068 $ 4,256 (1) Long-lived assets are comprised of property and equipment, net and operating lease right-of use. c. Financial income, net: Years ended December 31, 2021 2020 2019 Financial Income: Interest income $ 666 $ 1,133 $ 1,775 Foreign currency exchange gain 250 878 338 916 2,011 2,113 Financial expenses: Bank charges (15 ) (15 ) (16 ) Foreign currency exchange loss (547 ) (1,186 ) (925 ) (562 ) (1,201 ) (941 ) $ 354 $ 810 $ 1,172 d. Net loss per Ordinary Share: The following table sets forth the computation of basic and diluted net income (loss) per Ordinary Share: Years ended December 31, 2021 2020 2019 Numerator: Numerator for basic net loss per Ordinary Share $ (5,263 ) $ (3,992 ) $ (6,832 ) Effect of dilutive securities: Share-based compensation granted - - - Numerator for dilutive net loss per Ordinary Share $ (5,263 ) $ (3,992 ) $ (6,832 ) Denominator: Denominator for dilutive net loss per Ordinary Share - weighted average number of Ordinary Shares 14,124,404 13,927,788 13,779,885 Effect of dilutive securities: Share-based compensation granted - - - Denominator for diluted net loss per Ordinary 14,124,404 13,927,788 13,779,885

Related Party Balances and Tran

Related Party Balances and Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY BALANCES AND TRANSACTIONS	NOTE 13: - RELATED PARTY BALANCES AND TRANSACTIONS a. The Company carries out transactions with related parties as detailed below. 1. Certain premises occupied by the Company and its U.S. subsidiary are rented from related parties in which Mr. Zohar Zisapel holds an interest (see also Note 9). The aggregate net amounts of lease and related maintenance expenses were $830, $863 and $912 in 2021, 2020 and 2019, respectively. Following the adoption of ASC 842 commencing January 1, 2019, the Company also recorded operating lease right-of use assets and operating lease liabilities related to such lease and maintenance expenses which are presented in Note 13e below. 2. Mr. Zisapel also holds an interest in and serves as director for various entities known as the RAD-BYNET Group. Certain entities within the RAD-BYNET Group provide the Company and its U.S. subsidiary with administrative and IT services. The aggregate amounts of administrative and IT services provided were $33, $30 and $49 in 2021, 2020 and 2019, respectively. Such amounts expensed by the Company are disclosed in Note 13f below as part of “Expenses” and “Capital expenses”. 3. From time to time, the Company purchases certain products and services from members of the RAD-BYNET Group. No such purchases were made in 2019, however, in 2021 and 2020, the aggregate amounts of such purchases were approximately $446 and $52, respectively. Such amounts expensed by the Company are disclosed in Note 13f below as part of “Expenses”. b. The executive chairman of the Board, Ms. Rachel (Heli) Bennun (the “Executive Chairman”) is, among other things, Mr. Zisapel’s significant other. The Executive Chairman is entitled to a fixed monthly salary. During the years ended December 31, 2021, 2020 and 2019 the Company recorded salary expenses with respect to the Executive Chairman in the amount of $119, $112 and $108, respectively. Such amounts expensed by the Company are disclosed in Note 13f below as part of “Expenses”. c. The Company’s former Chief Financial Officer is a member of the board of directors and chairman of the audit committee of Matrix IT Ltd. (“Matrix”). Accordingly, as of October 2019, Matrix is considered a related party. The Company has entered into certain limited term engagements with Matrix or its affiliated companies in connection with specific development projects and/or use of software platform. The aggregate services provided by Matrix or its affiliates, as a related party, amounted to $121, $67 and $288 during the years ended December 31, 2021, 2020 and 2019, respectively. Such amount expensed by the Company is disclosed in Note 13f below as part of “Expenses”. d. Balances with related parties: December 31, 2021 2020 Assets: Other accounts receivable and prepaid $ 165 $ - Operating lease right-of-use assets $ 1,303 $ 1,997 Liabilities: Trade payables $ 194 $ 76 Other liabilities and accrued expenses $ 88 $ 49 Operating lease liabilities - current $ 778 $ 671 Operating lease liabilities – non-current $ 615 $ 1,352 e. Transactions with related parties: Year ended December 31, 2021 2020 2019 Expenses (1): Cost of revenues $ 189 $ 215 $ 320 Operating expenses: Research and development, net $ 1,083 $ 653 $ 829 Sales and marketing $ 194 $ 191 $ 172 General and administrative $ 212 $ 206 $ 211 Capital expenses $ 29 $ - $ 12 (1) Including utilities expenses charged to the related party and reimbursed by the Company.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 14: - SUBSEQUENT EVENTS During February 2022, the Company’s Board approved the grant of 298,000 RSUs to certain employees and officers of the Company. Such RSUs have vesting schedules of 2-4 years, commencing as of the date of grant.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Use of estimates	a. Use of estimates: The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Financial statements in U.S. dollars (“$” “dollar” or “dollars”):	b. Financial statements in U.S. dollars (“$” “dollar” or “dollars”): Most of the revenues of the Company and its subsidiaries, other than the Company’s subsidiary in Brazil, are denominated in U.S. dollars. Financing activities are made in U.S. dollars. Therefore, the Company’s management believes that the currency of the primary economic environment in which the operations of the Company and its subsidiaries are conducted is the dollar, which is used as the functional currency. Transactions and balances originally denominated in dollars are presented at their original amounts. Transactions and balances in other currencies are re-measured into dollars in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 830 “Foreign Currency Matters.” Other than in the Company’s subsidiary in Brazil, all exchange gains and losses from Amounts in the financial statements representing the dollar equivalent of balances denominated in other currencies do not necessarily represent their real or economic value and such amounts may not necessarily be exchangeable for dollars. For the Company’s subsidiary in Brazil whose functional currency is the BRL, all amounts on the balance sheets have been translated into the dollar using the exchange rates in effect on the relevant balance sheet dates. All amounts in the statements of operations have been translated into the dollar using the exchange rate on the respective dates on which those elements are recognized. The resulting translation adjustments are reported as a component of accumulated other comprehensive income in shareholders’ equity.
Principles of consolidation	c. Principles of consolidation: The consolidated financial statements include the financial statements of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Cash and cash equivalents	d. Cash and cash equivalents: The Company considers all highly liquid deposit instruments with an original maturity of three months or less at the date of purchase to be cash equivalents.
Short-term bank deposits	e. Short-term bank deposits: Short-term bank deposits are deposits with maturities of more than three months but less than one year and which do not meet the definition of cash equivalents . Such deposits include annual interest rates ranging between 0.56%-1.6% resulting in accrued interest of $144
Trade receivables	f. Trade receivables: Trade receivables are recorded and carried at the original invoiced amount which was recognized as revenues less an allowance for credit losses. The Company grants credit to customers without generally requiring collateral or security. The Company makes estimates of expected credit losses based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company’s consolidated statements of income (loss). Allowance for credit losses as of December 31, 2020 and 2021, amounted to $5 for both years.
Concentration of credit risk	g. Concentration of credit risk: Financial instruments that may subject the Company to significant concentration of credit risk consist mainly of cash and cash equivalents, short-term bank deposits, severance pay fund and trade receivables. Cash and cash equivalents are maintained with major financial institutions mainly in Israel. Assets held for severance benefits are maintained with major insurance companies and financial institutions in Israel. Such deposits are not insured. However, management believes that such financial institutions are financially sound and, accordingly, low credit risk exists with respect to these investments.
Inventories	h. Inventories: Inventories are stated at the lower of cost and net realizable value. The cost of inventories comprises costs of purchase and costs incurred in bringing the inventories to their present location and condition. Inventory write-offs are provided to cover technological obsolescence, excess inventories and discontinued products. Inventory write-off is measured as the difference between the cost of the inventory and net realizable value based upon assumptions about future demand and is charged to the cost of revenues. At the point of the loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. The total inventory write-offs during the year ended December 31, 2020 amounted to $14. No inventory write-offs were recorded during the years ended December 31, 2021 and 2019.
Property and equipment	i. Property and equipment: Property and equipment are stated at cost less accumulated depreciation. Maintenance and repairs are charged to operations as incurred. Depreciation is calculated on the straight-line method over the estimated useful lives of the assets. Annual rates of depreciation are as follows: % Computers and electronic equipment 15 - 33 Office furniture and equipment 6 - 20 Leasehold improvements At the shorter of the lease period or useful life of the leasehold improvement
Impairment of long-lived assets	j. Impairment of long-lived assets: The Company’s long-lived assets are reviewed for impairment in accordance with ASC 360, “Property, plants and equipment”, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of an asset to be held and used is assessed by a comparison of the carrying amount of the asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds its fair value. During the years ended December 31, 2021, 2020 and 2019, no impairment losses were identified.
Leases	k. Leases Under ASC 842, “Leases” (“ASC 842”), the Company determines if an arrangement is a lease at inception. The Company’s assessment is based on: (1) whether the contract includes an identified asset, (2) whether the Company obtains substantially all of the economic benefits from the use of the asset throughout the period of use, and (3) whether the Company has the right to direct how and for what purpose the identified asset is used throughout the period. The Company elected the package of practical expedients permitted under the standard related to treating lease and non-lease components as a single lease component for all equipment leases as well as electing a policy exclusion permitting leases with an original lease term of less than one year to be excluded from the operating lease right-of-use (“ROU”) assets and operating lease liabilities. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and operating lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company consider only payments that are fixed and determinable at the time of commencement. The Company uses its incremental borrowing rate based on the information available at the commencement date to determine the present value of the lease payments. Several of the Company’s leases include options to extend the lease and some have termination options that are factored into the Company’s determination of the lease payments when appropriate. For purposes of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. The Company’s lease agreements do not contain any material residual value guarantees. Operating lease expenses are recognized on a straight-line basis over the lease term. For all short-term leases which are less than 12 months and existing short-term leases of those assets in transition, the Company does not recognize operating lease ROU assets or operating lease liabilities, but recognizes lease expenses over the lease term on a straight-line basis. See Note 9 for further information on leases.
Revenue recognition	l. Revenue recognition: The Company’s solution is sold to customers directly, through resellers and to lesser extent through distributors. Sales through resellers are considered final sales per revenue recognition criteria. The Company recognizes revenues in accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation as follows: a) Identify the contract with a customer: b) Identify the performance obligations in the contract: c) Determine the transaction price: Generally, the Company doesn’t grant its customers a right to return the products sold. However, in some cases, the arrangements may include refunds, liquidated damages, penalties or other damages if the Company fails to deliver future goods or services or if the goods or services fail to meet certain specifications to acceptance criteria. All of the above are accounted for as variable considerations, which may result in an adjustment to the transaction price. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company’s estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available. The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is a year or less. As the period of time between delivery and payment for most of the Company's contracts is less than one year, these contracts are not assessed for a significant financing component. In other contracts, the Company determined that those contracts generally do not include a significant financing component, as the primary purpose of the invoicing terms for these contracts is to provide customers with simplified and predictable ways of purchasing the Company's products and services, not to receive or provide financing. d) Allocate the transaction price to the performance obligations in the contract: The Company’s selling price is highly variable. e) Recognize revenue when a performance obligation is satisfied: Products Services: Projects: Deferred revenues represent unrecognized fees collected as well as other advances and payments received from customers, for which revenue has not yet been recognized. Deferred revenues are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized. See also Note 3 for additional revenue recognition disclosures.
Cost of revenues	m. Cost of revenues: Cost of revenues is comprised of cost of third-party hardware and software license fees, maintenance fees related to such third-party hardware and software, employees’ salaries and related costs, shipping and handling costs, subcontractors, inventory write-offs, indirect taxes, importation taxes and royalties to the Israel Innovation Authority (the “IIA”).
Share-based compensation	n. Share-based compensation: The Company accounts for share-based compensation in accordance with ASC 718, “Compensation — Stock Compensation”, which requires companies to estimate the fair value of share-based payment awards on the grant date using an option-pricing model. The Company recognizes compensation expenses for the value of its awards over the requisite service period of each of the awards. For graded vesting awards subject to service conditions only, the Company uses the straight-line attribution method. The Company estimates expected forfeitures. The Company selected the Black-Scholes option-pricing model as the most appropriate fair value method for its share-options awards. The option-pricing model requires a number of assumptions, of which the most significant are the expected share price volatility and the expected option term. Expected volatility was calculated based upon actual historical share price movements over the most recent periods ending on the grant date, equal to the expected option term. The expected term was generated by running the Monte Carlo model pursuant to which historical post-vesting forfeitures and suboptimal exercise factor are estimated by using historical option exercise information. The suboptimal exercise factor is the ratio by which the share price must increase over the exercise price before employees are expected to exercise their share options. The expected term of the options granted is derived from the output of the options valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on the yield from U.S. Treasury zero-coupon bonds with an equivalent term to the expected term of the options. Historically the Company has not paid dividends and in addition has no foreseeable plans to pay dividends, and therefore uses an expected dividend yield of zero in the option-pricing model No options were granted in 2021 and 2019. The fair value for options granted in 2020 is estimated at the date of grant with the following weighted average assumptions: 2020 Dividend yield 0% Expected exercise factor 2.67 Expected volatility 41.92%-45.21% Risk-free interest 0.25%-0.27% Expected life (in years) 4.32-4.75 Change in Accounting Principle - Share-based Compensation In 2021, the Company elected to change its accounting policy for recognizing share-based compensation expense for graded vesting share awards subject to service conditions only by applying the straight-line attribution method instead of the accelerated attribution method and using an estimated forfeiture rate of awards expected to be forfeited for each award rather than account for the forfeitures as they occur. The change in the recognition of share-based compensation expense represents a change in accounting principle which the Company believes to be preferable because the straight-line attribution method is the predominant method used in its industry and because estimating forfeitures will result in a more accurate attribution of share-based compensation expense since the Company has accumulated during the last few years sufficient historical experience to make a reasonable estimate of the forfeiture pattern of its employees.
Research and development costs	o. Research and development costs: Research and development costs are charged to the statement of operations as incurred except for royalty-bearing participation from the IIA as described in Note 2p. ASC 985-20, “Software - Costs of Computer Software to be Sold, Leased or Otherwise Marketed”, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company’s product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release have been insignificant. Therefore, all research and development costs have been expensed.
Government grants	p. Government grants: The Company receives royalty-bearing grants, which represent participation of the IIA in approved programs for research and development. These amounts are recognized on the accrual basis as a reduction of research and development costs as such costs are incurred. Royalties to the IIA are recorded under cost of revenues, when the related sales are recognized (see also Note 8a1). During the years 2012 to 2017, the Company also received grants from the Israeli Ministry of Economy (the “MOE”), up to 50% of relevant marketing expenses. These grants were presented as a reduction of marketing expenses (see also Note 8a2).
Income (loss) per share	q. Income (loss Basic and diluted income (loss) per Ordinary Share is presented in conformity with ASC 260, “Earnings Per Share”, for all years presented. Basic income (loss) per Ordinary Share is computed by dividing net income (loss) for each reporting period by the weighted average number of Ordinary Shares outstanding during the period. Diluted income (loss) per Ordinary Share is computed by dividing net income (loss) for each reporting period by the weighted average number of Ordinary Shares outstanding during the period plus any additional Ordinary Shares that would have been outstanding if potentially dilutive securities had been exercised during the period, calculated under the treasury stock method. Certain securities were not included in the computation of diluted income (loss) per share since they were anti-dilutive. The total weighted average number of shares related to the outstanding options and restricted share units (“RSUs”) excluded from the calculation of diluted net income (loss) per share was, 956,356, 877,195 and 802,159 for the years ended December 31, 2021, 2020 and 2019, respectively.
Income taxes	r. Income taxes: The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". Deferred tax asset and liability account balances are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statement of operations in the period that includes the enactment date. Deferred tax assets and liabilities are classified as noncurrent on the balance sheet. The Company provides a full valuation allowance to reduce deferred tax assets to the extent it believes it is more likely than not that such benefits will be realized.
Income tax uncertainties	s. Income tax uncertainties: In accordance with ASC 740, the Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% of the amount likely to be realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. When applicable, the Company accounts for interest and penalties related to unrecognized tax benefits as a component of income tax expense. As of December 31, 2021 and 2020, no liability for unrecognized tax benefits was recorded.
Severance pay	t. Severance pay: The Company’s liability for severance pay is recorded mainly with respect to its Israeli employees and is calculated pursuant to Israeli severance pay law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. After completing one full year of employment, the Company’s Israeli employees are entitled to one month’s salary for each year of employment or a portion thereof. The Company’s liability is partially provided by monthly deposits with severance pay funds, insurance policies and by an accrual. The liability for employee severance pay benefits included on the balance sheet represents the total liability for such severance benefits, while the assets held for severance benefits included on the balance sheet represent the current redemption value of the Company’s contributions made to severance pay funds and to insurance policies. The carrying value of deposited funds includes profits (losses) accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements. Effective January 1, 2012, the Company’s agreements with new employees in Israel are in accordance with section 14 of the Severance Pay Law – 1963, which provides that the Company’s contributions to the severance pay fund shall cover its entire severance obligation. Upon termination, the release of the contributed amounts from the fund to the employee shall relieve the Company from any further severance obligation and no additional payments shall be made by the Company to the employee. As a result, the related obligation and amounts deposited on behalf of such obligation are not recorded as part of the balance sheet, as the Company is legally released from its severance obligation to employees once the amounts have been deposited, and the Company has no further legal ownership of the amounts deposited. Severance expenses for the years ended December 31, 2021, 2020 and 2019 amounted to $922, $1,195, and $1,150, respectively.
Fair value of financial instruments	u. Fair value of financial instruments: The Company follows the provisions of ASC No. 820, “Fair Value Measurement”, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining a fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing an asset or liability, based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect assumptions that market participants would use in pricing an asset or liability, based on the best information available under given circumstances. The hierarchy is broken down into three levels, based on the observability of inputs and assumptions, as follows: Level 1 - Observable inputs obtained from independent sources, such as quoted prices for identical assets and liabilities in active markets. Level 2 - Other inputs that are directly or indirectly observable in the marketplace. Level 3 - Unobservable inputs which are supported by little or no market activity. The financial instruments of the Company consist mainly of cash and cash equivalents, short-term bank deposits, trade receivables, trade payables and other liabilities and accrued expenses. The fair values of the Company cash and cash equivalents, account receivables, and account payables approximate their carrying amounts due to their short-term nature.
Legal contingencies	v. Legal contingencies: From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. The Company’s estimations and related accruals if any are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events relating to a particular matter.
Comprehensive income (loss)	w. Comprehensive income (loss): The Company accounts for comprehensive income (loss) in accordance with ASC 220, “Comprehensive Income”, which establishes standards for the reporting and displays of comprehensive income and its components in a full set of general-purpose financial statements. Comprehensive income generally represents all changes in shareholders’ equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its only item of other comprehensive income relates to foreign currency translation adjustment and gains or losses on intercompany foreign currency transactions that are of a long-term investment nature in connection with its subsidiary in Brazil.
Recently issued and adopted accounting standards	x. Recently issued and adopted accounting standards: In December 2019, the FASB issued Accounting Standards Update (“ASU”) No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2020-12”), which simplifies the accounting for income taxes. ASU 2019-12 is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2020. The adoption of this standard did not have a material effect on the Company’s consolidated financial statements.
Recently issued accounting standards	y. Recently issued accounting standards: In November 2021, the FASB issued ASU No. 2021-10, Government Assistance (Topic 832): Disclosure by Business Entities about Government Assistance (ASU 2021-10), which improves the transparency of government assistance received by most business entities by requiring the disclosure of: (1) the types of government assistance received; (2) the accounting for such assistance; and (3) the effect of the assistance on a business entity's financial statements. This guidance is effective for financial statements issued for annual periods beginning after December 15, 2021. Early adoption is permitted. The Company will adopt this standard on January 1, 2022. The Company does not expect that the adoption of this standard will result in a material impact on the Company's consolidated financial statements.

Significant Accounting Polici_2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of annual rates of depreciation	% Computers and electronic equipment 15 - 33 Office furniture and equipment 6 - 20 Leasehold improvements At the shorter of the lease period or useful life of the leasehold improvement
Schedule of fair value for options granted	2020 Dividend yield 0% Expected exercise factor 2.67 Expected volatility 41.92%-45.21% Risk-free interest 0.25%-0.27% Expected life (in years) 4.32-4.75

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Schedule of inventories	December 31, 2021 2020 Finished products (*) $ 931 $ 540 (*) Includes amounts of $570 and $399 as of December 31, 2021 and 2020, respectively, with respect to inventory delivered to customers for which control has not been transferred.

Other Accounts Receivable and_2

Other Accounts Receivable and Prepaid Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Prepaid Expense and Other Assets [Abstract]
Schedule of other accounts receivable and prepaid expenses	December 31, 2021 2020 Governmental authorities $ 340 $ 252 Prepaid expenses 1,593 1,135 Others 31 50 $ 1,964 $ 1,437

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of composition of assets grouped by major classification	December 31, 2021 2020 Cost: Computers and electronic equipment $ 4,235 $ 3,806 Office furniture and equipment 404 392 Leasehold improvements 297 277 4,936 4,475 Accumulated depreciation: Computers and electronic equipment 3,399 2,945 Office furniture and equipment 179 151 Leasehold improvements 98 68 3,676 3,164 $ 1,260 $ 1,311

Other Current Liabilities and_2

Other Current Liabilities and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Schedule of other current liabilities and accrued expenses	December 31, 2021 2020 Royalties - IIA payable $ 1,026 $ 986 Accrued commissions 1,040 2,018 Accrued expenses 3,362 1,717 $ 5,428 $ 4,721

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Schedule of weighted-average remaining lease term and discount rate	December 31, December 31, 2021 2020 Weighted average remaining lease term 1.84 years 2.20 years Weighted average discount rate 4.92 % 4.46 %
Schedule of lease expense	Year ended Year ended December 31, 2021 December 31, 2020 Operating lease $ 1,173 $ 1,223 Short-term lease 5 6 Total lease expense $ 1,178 $ 1,229
Schedule of maturities of lease liabilities	Operating Leases 2022 1,014 2023 340 2024 208 2025 129 2026 and thereafter 302 Total operating lease payments $ 1,993 Less: imputed interest 54 Present value of lease liabilities $ 1,939

Taxes on Income (Tables)

Taxes on Income (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of significant components of deferred tax assets and liabilities	December 31 2021 2020 Deferred tax assets: Carryforward tax losses $ 10,540 $ 10,391 Research and development 3,227 2,862 Accrued social benefits and other 505 567 14,272 13,820 Less - valuation allowance (14,272 ) (13,820 ) Net deferred tax assets $ - $ -
Schedule of components of income (loss) before income taxes	Year ended December 31, 2021 2020 2019 Domestic $ (6,030 ) $ (4,271 ) $ (7,107 ) Foreign 891 499 444 Loss before income taxes $ (5,139 ) $ (3,772 ) $ (6,663 )
Schedule of reconciliation of theoretical tax benefit and actual tax expense	Year ended December 31, 2021 2020 2019 Loss before income taxes, as reported in the statements of operations $ (5,139 ) $ (3,772 ) $ (6,663 ) Statutory tax rate in Israel 23 % 23 % 23 % Theoretical tax benefit $ (1,182 ) $ (868 ) $ (1,532 ) Increase (decrease) in income taxes resulting from: Tax rate differential on foreign subsidiaries (31 ) (50 ) 12 Non-deductible expenses and other permanent differences 631 393 473 Differences in taxes arising from foreign currency exchange, net 69 257 42 Changes in carry forward tax losses and other temporary differences for which valuation allowance was provided 481 310 910 Other 156 178 264 Income taxes $ 124 $ 220 $ 169

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure Text Block Supplement [Abstract]
Schedule of stock options	Number of Weighted Weighted (in years) Aggregate Outstanding as of January 1, 2021 305,839 14.21 1.33 98 Granted - - Exercised - - Expired and forfeited (166,159 ) 12.40 Outstanding as of December 31, 2021 139,680 16.36 1.20 181 Vested and expected to vest at December 31, 2021 139,680 16.36 1.20 181 Exercisable as of December 31, 2021 121,155 17.70 0.85 85
Schedule of stock options under the 2013 share option plan	Options outstanding at December 31, 2021 Options exercisable at December 31, 2021 Exercise price Number outstanding Weighted average exercise price Weighted average remaining contractual life Number exercisable Weighted average exercise price Weighted average remaining contractual life $ $ In years $ In years 7.60 35,100 7.60 3.52 16,575 7.60 3.53 18.90 60,002 18.90 0.10 60,002 18.90 0.10 19.85 44,578 19.85 0.87 44,578 19.85 0.87 139,680 121,155
Schedule of RSUs under the company’s 2013 Share Option Plan	Number of Weighted (in years) Aggregate Outstanding as of January 1, 2021 551,175 1.51 $ 5,732 Granted 782,350 Vested (223,730 ) Cancelled (60,866 ) Outstanding as of December 31, 2021 1,048,929 1.54 $ 13,689
Schedule of department allocation of share-based compensation charges	Year ended December 31, 2021 (*) 2020 (*) 2019 (*) Cost of revenues $ 207 $ 106 $ 204 Research and development, net 1,368 879 729 Sales and marketing 865 536 638 General and administrative 916 648 657 $ 3,356 $ 2,169 $ 2,228 (*) Including $3,271, $2,107 and $1,887 of compensation cost related to RSUs for the years ended December 31, 2021, 2020 and 2019, respectively.

Selected Statements of Operat_2

Selected Statements of Operations Data (Tables)	12 Months Ended
	Dec. 31, 2021
Selected Statements of Operations Data [Abstract]
Schedule of revenues by geographic region	Year ended December 31, 2021 2020 2019 North America $ 21,777 $ 20,323 $ 14,500 Asia* 14,686 15,190 14,146 Latin America 1,071 223 2,653 EMEA (including Israel) 2,748 1,826 1,711 $ 40,282 $ 37,562 $ 33,010
Schedule of major customer percentage of revenue	Year ended December 31, 2021 2020 2019 A 52 53 41 B 26 29 22 C 10 11 20 88 % 93 % 83 %
Schedule of long-lived assets	Year ended December 31, 2021 2020 Israel $ 1,730 $ 2,633 United States 885 1,049 Other 453 574 Total long-lived assets (1) $ 3,068 $ 4,256
Schedule of financial income, net	Years ended December 31, 2021 2020 2019 Financial Income: Interest income $ 666 $ 1,133 $ 1,775 Foreign currency exchange gain 250 878 338 916 2,011 2,113 Financial expenses: Bank charges (15 ) (15 ) (16 ) Foreign currency exchange loss (547 ) (1,186 ) (925 ) (562 ) (1,201 ) (941 ) $ 354 $ 810 $ 1,172
Schedule of computation of basic and diluted net income (loss) per ordinary share	Years ended December 31, 2021 2020 2019 Numerator: Numerator for basic net loss per Ordinary Share $ (5,263 ) $ (3,992 ) $ (6,832 ) Effect of dilutive securities: Share-based compensation granted - - - Numerator for dilutive net loss per Ordinary Share $ (5,263 ) $ (3,992 ) $ (6,832 ) Denominator: Denominator for dilutive net loss per Ordinary Share - weighted average number of Ordinary Shares 14,124,404 13,927,788 13,779,885 Effect of dilutive securities: Share-based compensation granted - - - Denominator for diluted net loss per Ordinary 14,124,404 13,927,788 13,779,885

Related Party Balances and Tr_2

Related Party Balances and Transactions (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Schedule of balances with related parties	December 31, 2021 2020 Assets: Other accounts receivable and prepaid $ 165 $ - Operating lease right-of-use assets $ 1,303 $ 1,997 Liabilities: Trade payables $ 194 $ 76 Other liabilities and accrued expenses $ 88 $ 49 Operating lease liabilities - current $ 778 $ 671 Operating lease liabilities – non-current $ 615 $ 1,352
Schedule of transactions with related parties	Year ended December 31, 2021 2020 2019 Expenses (1): Cost of revenues $ 189 $ 215 $ 320 Operating expenses: Research and development, net $ 1,083 $ 653 $ 829 Sales and marketing $ 194 $ 191 $ 172 General and administrative $ 212 $ 206 $ 211 Capital expenses $ 29 $ - $ 12 (1) Including utilities expenses charged to the related party and reimbursed by the Company.

General (Details)

General (Details)	Dec. 31, 2021
Accounting Policies [Abstract]
Revenues percentage	88.00%

Significant Accounting Polici_3

Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2017
Significant Accounting Policies (Details) [Line Items]
Warrants excluded from calculation of diluted net income (loss) per share (in Shares)	956,356	877,195	802,159
Accrued interest	$ 144	$ 359
Net of allowances for doubtful accounts	5	5
Total inventory write-offs during period		14
Effect on decrease in net loss	$ 141
Effect on decrease in net loss per share (in Dollars per share)	$ 0.01
Percentage of marketing expenses				50.00%
Severance expenses	$ 922	$ 1,195	$ 1,150
Minimum [Member]
Significant Accounting Policies (Details) [Line Items]
Annual Interest rate	0.56%
Maximum [Member]
Significant Accounting Policies (Details) [Line Items]
Annual Interest rate	1.60%

Significant Accounting Polici_4

Significant Accounting Policies (Details) - Schedule of annual rates of depreciation	12 Months Ended
	Dec. 31, 2021
Leasehold improvements [Member]
Significant Accounting Policies (Details) - Schedule of annual rates of depreciation [Line Items]
Property and equipment, description	At the shorter of the lease period or useful life of the leasehold improvement
Minimum [Member] | Computers and electronic equipment [Member]
Significant Accounting Policies (Details) - Schedule of annual rates of depreciation [Line Items]
Property and equipment, percentage	15.00%
Minimum [Member] | Office furniture and equipment [Member]
Significant Accounting Policies (Details) - Schedule of annual rates of depreciation [Line Items]
Property and equipment, percentage	6.00%
Maximum [Member] | Computers and electronic equipment [Member]
Significant Accounting Policies (Details) - Schedule of annual rates of depreciation [Line Items]
Property and equipment, percentage	33.00%
Maximum [Member] | Office furniture and equipment [Member]
Significant Accounting Policies (Details) - Schedule of annual rates of depreciation [Line Items]
Property and equipment, percentage	20.00%

Significant Accounting Polici_5

Significant Accounting Policies (Details) - Schedule of fair value for options granted	12 Months Ended
	Dec. 31, 2020$ / shares
Significant Accounting Policies (Details) - Schedule of fair value for options granted [Line Items]
Dividend yield	0.00%
Expected exercise factor (in Dollars per share)	$ 2.67
Minimum [Member]
Significant Accounting Policies (Details) - Schedule of fair value for options granted [Line Items]
Expected volatility	41.92%
Risk-free interest	0.25%
Expected life (in years)	4 years 3 months 25 days
Maximum [Member]
Significant Accounting Policies (Details) - Schedule of fair value for options granted [Line Items]
Expected volatility	45.21%
Risk-free interest	0.27%
Expected life (in years)	4 years 9 months

Revenues (Details)

Revenues (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Revenues Disclosure [Abstract]
Deferred commission costs	$ 1,052	$ 1,994
New contract acquisition assets	248
Amortized of capitalized contract acquisition asset	1,190
Unbilled receivables balances amount	1,457	$ 2,570
Remaining performance obligations	$ 39,927
Percentage of revenues	67.00%
Deferred revenues	$ 2,333

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventory delivered to customers	$ 570	$ 399

Inventories (Details) - Schedul

Inventories (Details) - Schedule of inventories - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Schedule of inventories [Abstract]
Finished products	[1]	$ 931	$ 540
[1]	Includes amounts of $570 and $399 as of December 31, 2021 and 2020, respectively, with respect to inventory delivered to customers for which control has not been transferred.

Other Accounts Receivable and_3

Other Accounts Receivable and Prepaid Expenses (Details) - Schedule of other accounts receivable and prepaid expenses - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Schedule of other accounts receivable and prepaid expenses [Abstract]
Governmental authorities	$ 340	$ 252
Prepaid expenses	1,593	1,135
Others	31	50
Other accounts receivable and prepaid expenses, total	$ 1,964	$ 1,437

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Depreciation expenses	$ 540	$ 699	$ 752

Property and Equipment, Net (_2

Property and Equipment, Net (Details) - Schedule of composition of assets grouped by major classification - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Cost:
Cost	$ 4,936	$ 4,475
Accumulated depreciation:
Accumulated depreciation	3,676	3,164
Property, Plant and Equipment, Net	1,260	1,311
Computers and electronic equipment [Member]
Cost:
Cost	4,235	3,806
Accumulated depreciation:
Accumulated depreciation	3,399	2,945
Office furniture and equipment [Member]
Cost:
Cost	404	392
Accumulated depreciation:
Accumulated depreciation	179	151
Leasehold improvements [Member]
Cost:
Cost	297	277
Accumulated depreciation:
Accumulated depreciation	$ 98	$ 68

Other Current Liabilities and_3

Other Current Liabilities and Accrued Expenses (Details) - Schedule of other current liabilities and accrued expenses - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Schedule of other current liabilities and accrued expenses [Abstract]
Royalties - IIA payable	$ 1,026	$ 986
Accrued commissions	1,040	2,018
Accrued expenses	3,362	1,717
Total	$ 5,428	$ 4,721

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Commitments and Contingencies (Details) [Line Items]
Grants intended costs, description	The grant was intended to cover up to 50% from the costs of the office establishment, logistics expenses and hiring employees and consultants in India and China, based on the approved budget for the plan over a period of three years.
Marketing grants received amount	$ 668
Royalties rate, description	S Bi-National Industrial Research and Development Foundation (“BIRD-F”), the Company is required to pay royalties at a rate of 5% of sales of products developed with funds provided by the BIRD-F, up to an amount equal to 150% of the BIRD-F’s grant, linked to the United States CPI relating to such products.
Bank guarantee, description	As of December 31, 2021, the Company issued a bank guarantee to the Israeli Customs Authority that amounted to $40, which will expire on April 30, 2022.
Israel Innovation Authority [Member]
Commitments and Contingencies (Details) [Line Items]
Royalty payable range	3.00%
Percent of grants received paid in royalties	100.00%
Amount of royalties paid or accrued,	$ 53,288
Total research and development grants	48,403
Accumulated interest, grants	23,489
Accumulated royalties paid	18,604
Royalty expenses	$ 1,209	$ 1,127	$ 990
Israeli Ministry of Trade [Member]
Commitments and Contingencies (Details) [Line Items]
Royalty payable range	3.00%
Grant approved over a period	5 years
BIRD-F [Member]
Commitments and Contingencies (Details) [Line Items]
Accumulated royalties paid	$ 423
Proceeds from grants received	340
Linkage to CPI	627
Pay royalties up to an amount	$ 941	$ 518

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure Text Block [Abstract]
Operating lease right of use decreased		$ 1,717
Operating lease liability decreased		2,233
Foreign currency exchange gain		484
Operating income		32
Operating lease agreements options to extend, description	As of December 31, 2021, the Company’s assessment for the remaining lease term range between 0.9 years to 6.3 years, including options to extend part of the lease agreements for an additional 2 years and up to 5 years.
Measurement of operating lease liabilities	$ 1,125	$ 1,184

Leases (Details) - Schedule of

Leases (Details) - Schedule of weighted-average remaining lease term and discount rate	Dec. 31, 2021	Dec. 31, 2020
Schedule of weighted-average remaining lease term and discount rate [Abstract]
Weighted average remaining lease term	1 year 10 months 2 days	2 years 2 months 12 days
Weighted average discount rate	4.92%	4.46%

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of lease expense - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of lease expense [Abstract]
Operating lease	$ 1,173	$ 1,223
Short-term lease	5	6
Total lease expense	$ 1,178	$ 1,229

Leases (Details) - Schedule o_3

Leases (Details) - Schedule of maturities of lease liabilities $ in Thousands	Dec. 31, 2021USD ($)
Schedule of maturities of lease liabilities [Abstract]
2022	$ 1,014
2023	340
2024	208
2025	129
2026 and thereafter	302
Total operating lease payments	1,993
Less: imputed interest	54
Present value of lease liabilities	$ 1,939

Taxes on Income (Details)

Taxes on Income (Details) - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Dec. 31, 2016	Aug. 31, 2013	Dec. 31, 2021	Dec. 22, 2017
Taxes on Income (Details) [Line Items]
Income tax rate			23.00%
Tax credit carryforward, description		the tax rate on preferred income from a preferred enterprise in 2014-2016 will be 9% in certain areas in Israel (“Development Area A”) and 16% in other areas. In 2017, the tax rate at Development Area A was reduced to 7.5%.
Companies foreign currency exchange rate			90.00%
Subject to tax at a rate			4.00%
Tax loss carry forward (in Dollars)			$ 38,362
Capital loss (in Dollars)			$ 1,283
Maximum offset percentage of taxable income for tax period			30.00%
Net change in total valuation allowance (in Dollars)			$ 452
U.S. subsidiary [Member]
Taxes on Income (Details) [Line Items]
Income tax rate			21.00%
Tax credit carryforward, description			Such losses are available to offset any future U.S. taxable income of the U.S. subsidiary and will expire in the years 2022-2026 for federal tax purposes.	Changes include, but are not limited to, a U.S. federal corporate tax rate decrease from 35% to 21% effective for tax years beginning after December 31, 2017, the transition of U.S. international taxation from a worldwide tax system to a territorial system, and a one-time transition tax on the mandatory deemed repatriation of cumulative foreign earnings as of December 31, 2017.
Tax loss carry forward (in Dollars)			$ 2,328
Brazilian subsidiary [Member]
Taxes on Income (Details) [Line Items]
Income tax rate			34.00%
Tax loss carry forward (in Dollars)			$ 2,740
Indian subsidiary [Member]
Taxes on Income (Details) [Line Items]
Income tax rate			25.00%
Development area A [Member]
Taxes on Income (Details) [Line Items]
Income tax rate	7.50%
Other areas [Member]
Taxes on Income (Details) [Line Items]
Income tax rate	12.00%
Research and Development Expense [Member]
Taxes on Income (Details) [Line Items]
Tax loss carry forward (in Dollars)			$ 14,029

Taxes on Income (Details) - Sch

Taxes on Income (Details) - Schedule of significant components of deferred tax assets and liabilities - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Carryforward tax losses	$ 10,540	$ 10,391
Research and development	3,227	2,862
Accrued social benefits and other	505	567
Deferred tax assets, gross	14,272	13,820
Less - valuation allowance	(14,272)	(13,820)
Net deferred tax assets

Taxes on Income (Details) - S_2

Taxes on Income (Details) - Schedule of components of income (loss) before income taxes - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of components of income (loss) before income taxes [Abstract]
Domestic	$ (6,030)	$ (4,271)	$ (7,107)
Foreign	891	499	444
Loss before income taxes	$ (5,139)	$ (3,772)	$ (6,663)

Taxes on Income (Details) - S_3

Taxes on Income (Details) - Schedule of reconciliation of theoretical tax benefit and actual tax expense - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of reconciliation of theoretical tax benefit and actual tax expense [Abstract]
Loss before income taxes, as reported in the statements of operations	$ (5,139)	$ (3,772)	$ (6,663)
Statutory tax rate in Israel	23.00%	23.00%	23.00%
Theoretical tax benefit	$ (1,182)	$ (868)	$ (1,532)
Increase (decrease) in income taxes resulting from:
Tax rate differential on foreign subsidiaries	(31)	(50)	12
Non-deductible expenses and other permanent differences	631	393	473
Differences in taxes arising from foreign currency exchange, net	69	257	42
Changes in carry forward tax losses and other temporary differences for which valuation allowance was provided	481	310	910
Other	156	178	264
Income taxes	$ 124	$ 220	$ 169

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Shareholders' Equity (Details) [Line Items]
Ordinary shares issued	5,189
Ordinary shares held by the company		30,843,000
Weighted average fair values of RSUs granted (in Dollars per share)		$ 3.41
Restricted Stock Units (RSUs) [Member]
Shareholders' Equity (Details) [Line Items]
Shares grant of RSUs	782,350	35,100	388,020
Stock option vesting period			4 years
Weighted average fair values of RSUs granted (in Dollars per share)	$ 11.36	$ 9.31	$ 7.86
Compensation cost (in Dollars)	$ 3,271	$ 2,107	$ 1,887
Total unrecognized costs related to non-vested share-based compensation (in Dollars)	$ 6,749
Recognized over a weighted average period	1 year
2013 Share Option Plan [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares issued	1,544,676
Shares grant of RSUs		340,000
Total number of shares reserved under share option plan	3,950,000
Minimum [Member] | Restricted Stock Units (RSUs) [Member]
Shareholders' Equity (Details) [Line Items]
Stock option vesting period	2 years	2 years
Maximum [Member] | Restricted Stock Units (RSUs) [Member]
Shareholders' Equity (Details) [Line Items]
Stock option vesting period	4 years	4 years

Shareholders' Equity (Details)

Shareholders' Equity (Details) - Schedule of stock options - Employee Stock [Member] $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)$ / sharesshares
Shareholders' Equity (Details) - Schedule of stock options [Line Items]
Number of options, Outstanding, Beginning balance | shares	305,839
Weighted average exercise price, Outstanding, Beginning balance | $ / shares	$ 14.21
Weighted average remaining contractual term (in years), Outstanding, Beginning balance	1 year 3 months 29 days
Aggregate intrinsic value, Outstanding, Beginning balance | $	$ 98
Number of options, Outstanding, Ending balance | shares	139,680
Weighted average exercise price, Outstanding, Ending balance | $ / shares	$ 16.36
Weighted average remaining contractual term (in years), Outstanding, Ending balance	1 year 2 months 12 days
Aggregate intrinsic value, Outstanding, Ending balance | $	$ 181
Number of options, Granted | shares
Weighted average exercise price, Granted | $ / shares
Number of options, Exercised | shares
Weighted average exercise price, Exercised | $ / shares
Number of options, Expired and forfeited | shares	(166,159)
Weighted average exercise price, Expired and forfeited | $ / shares	$ 12.4
Number of options, Outstanding, Vested and expected to vest | shares	139,680
Weighted average exercise price, Vested and expected to vest | $ / shares	$ 16.36
Weighted average remaining contractual term (in years), Vested and expected to vest	1 year 2 months 12 days
Aggregate intrinsic value, Vested and expected to vest | $	$ 181
Number of options, Exercisable | shares	121,155
Weighted average exercise price, Exercisable | $ / shares	$ 17.7
Weighted average remaining contractual term (in years), Exercisable	10 months 6 days
Aggregate intrinsic value, Exercisable | $	$ 85

Shareholders' Equity (Details_2

Shareholders' Equity (Details) - Schedule of stock options under the 2013 share option plan	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Shareholders' Equity (Details) - Schedule of stock options under the 2013 share option plan [Line Items]
Options outstanding, Number outstanding (in Shares) | shares	139,680
Options exercisable, Number exercisable (in Shares) | shares	121,155
7.60 [Member]
Shareholders' Equity (Details) - Schedule of stock options under the 2013 share option plan [Line Items]
Options outstanding, Number outstanding (in Shares) | shares	35,100
Options outstanding, Weighted average exercise price	$ 7.6
Options outstanding, Weighted average remaining contractual life	3 years 6 months 7 days
Options exercisable, Number exercisable (in Shares) | shares	16,575
Options exercisable, Weighted average exercise price	$ 7.6
Options exercisable, Weighted average remaining contractual life	3 years 6 months 10 days
7.60 [Member] | Minimum [Member]
Shareholders' Equity (Details) - Schedule of stock options under the 2013 share option plan [Line Items]
Exercise price	$ 7.6
18.90 [Member]
Shareholders' Equity (Details) - Schedule of stock options under the 2013 share option plan [Line Items]
Options outstanding, Number outstanding (in Shares) | shares	60,002
Options outstanding, Weighted average exercise price	$ 18.9
Options outstanding, Weighted average remaining contractual life	1 month 6 days
Options exercisable, Number exercisable (in Shares) | shares	60,002
Options exercisable, Weighted average exercise price	$ 18.9
Options exercisable, Weighted average remaining contractual life	1 month 6 days
18.90 [Member] | Minimum [Member]
Shareholders' Equity (Details) - Schedule of stock options under the 2013 share option plan [Line Items]
Exercise price	$ 18.9
19.85 [Member]
Shareholders' Equity (Details) - Schedule of stock options under the 2013 share option plan [Line Items]
Options outstanding, Number outstanding (in Shares) | shares	44,578
Options outstanding, Weighted average exercise price	$ 19.85
Options outstanding, Weighted average remaining contractual life	10 months 13 days
Options exercisable, Number exercisable (in Shares) | shares	44,578
Options exercisable, Weighted average exercise price	$ 19.85
Options exercisable, Weighted average remaining contractual life	10 months 13 days
19.85 [Member] | Minimum [Member]
Shareholders' Equity (Details) - Schedule of stock options under the 2013 share option plan [Line Items]
Exercise price	$ 19.85

Shareholders' Equity (Details_3

Shareholders' Equity (Details) - Schedule of RSUs under the company’s 2013 Share Option Plan - Restricted Stock Units (RSUs) [Member] $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)shares
Shareholders' Equity (Details) - Schedule of RSUs under the company’s 2013 Share Option Plan [Line Items]
Number of RSUs, Outstanding, beginning balance	551,175
Weighted average remaining contractual term (in years), Outstanding, beginning balance	1 year 6 months 3 days
Aggregate intrinsic value, Outstanding, beginning balance (in Dollars) | $	$ 5,732
Number of RSUs, Granted	782,350
Number of RSUs, Vested	(223,730)
Number of RSUs, Cancelled	(60,866)
Number of RSUs, Outstanding, ending balance	1,048,929
Weighted average remaining contractual term (in years), Outstanding, ending balance	1 year 6 months 14 days
Aggregate intrinsic value, Outstanding, ending balance (in Dollars) | $	$ 13,689

Shareholders' Equity (Details_4

Shareholders' Equity (Details) - Schedule of department allocation of share-based compensation charges - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation	[1]	$ 3,356	$ 2,169	$ 2,228
Cost of revenues [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation	[1]	207	106	204
Research and development, net [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation	[1]	1,368	879	729
Sales and marketing [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation	[1]	865	536	638
General and administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation	[1]	$ 916	$ 648	$ 657
[1]	Including $3,271, $2,107 and $1,887 of compensation cost related to RSUs for the years ended December 31, 2021, 2020 and 2019, respectively.

Selected Statements of Operat_3

Selected Statements of Operations Data (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Selected Statements of Operations Data (Details) [Line Items]
Number of reportable segments	1
Concentration risk, percentage	94.00%	96.00%	96.00%
Revenues [Member]
Selected Statements of Operations Data (Details) [Line Items]
Company’s revenue, percentage	10.00%

Selected Statements of Operat_4

Selected Statements of Operations Data (Details) - Schedule of revenues by geographic region - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Selected Statements of Operations Data (Details) - Schedule of revenues by geographic region [Line Items]
Revenues		$ 40,282	$ 37,562	$ 33,010
North America [Member]
Selected Statements of Operations Data (Details) - Schedule of revenues by geographic region [Line Items]
Revenues		21,777	20,323	14,500
Asia [Member]
Selected Statements of Operations Data (Details) - Schedule of revenues by geographic region [Line Items]
Revenues	[1]	14,686	15,190	14,146
Latin America [Member]
Selected Statements of Operations Data (Details) - Schedule of revenues by geographic region [Line Items]
Revenues		1,071	223	2,653
EMEA (including Israel) [Member]
Selected Statements of Operations Data (Details) - Schedule of revenues by geographic region [Line Items]
Revenues		$ 2,748	$ 1,826	$ 1,711
[1]	Includes Japan and the Philippines which accounted for more than 10% of Company’s revenues in all years presented.

Selected Statements of Operat_5

Selected Statements of Operations Data (Details) - Schedule of major customer percentage of revenue	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Selected Statements of Operations Data (Details) - Schedule of major customer percentage of revenue [Line Items]
Percentage of total revenues	88.00%	93.00%	83.00%
Customer A [Member]
Selected Statements of Operations Data (Details) - Schedule of major customer percentage of revenue [Line Items]
Percentage of total revenues	52.00%	53.00%	41.00%
Customer B [Member]
Selected Statements of Operations Data (Details) - Schedule of major customer percentage of revenue [Line Items]
Percentage of total revenues	26.00%	29.00%	22.00%
Customer C [Member]
Selected Statements of Operations Data (Details) - Schedule of major customer percentage of revenue [Line Items]
Percentage of total revenues	10.00%	11.00%	20.00%

Selected Statements of Operat_6

Selected Statements of Operations Data (Details) - Schedule of long-lived assets - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Selected Statements of Operations Data (Details) - Schedule of long-lived assets [Line Items]
Total long-lived assets	[1]	$ 3,068	$ 4,256
Israel [Member]
Selected Statements of Operations Data (Details) - Schedule of long-lived assets [Line Items]
Total long-lived assets		1,730	2,633
United States [Member]
Selected Statements of Operations Data (Details) - Schedule of long-lived assets [Line Items]
Total long-lived assets		885	1,049
Other [Member]
Selected Statements of Operations Data (Details) - Schedule of long-lived assets [Line Items]
Total long-lived assets		$ 453	$ 574
[1]	Long-lived assets are comprised of property and equipment, net and operating lease right-of use.

Selected Statements of Operat_7

Selected Statements of Operations Data (Details) - Schedule of financial income, net - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financial Income:
Interest income	$ 666	$ 1,133	$ 1,775
Foreign currency exchange gain	250	878	338
Financial income	916	2,011	2,113
Financial expenses:
Bank charges	(15)	(15)	(16)
Foreign currency exchange loss	(547)	(1,186)	(925)
Financial expenses	(562)	(1,201)	(941)
Financial income, net	$ 354	$ 810	$ 1,172

Selected Statements of Operat_8

Selected Statements of Operations Data (Details) - Schedule of computation of basic and diluted net income (loss) per ordinary share - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Numerator:
Numerator for basic net loss per Ordinary Share	$ (5,263)	$ (3,992)	$ (6,832)
Effect of dilutive securities:
Share-based compensation granted
Numerator for dilutive net loss per Ordinary Share	$ (5,263)	$ (3,992)	$ (6,832)
Denominator:
Denominator for dilutive net loss per Ordinary Share - weighted average number of Ordinary Shares (in Shares)	14,124,404	13,927,788	13,779,885
Effect of dilutive securities:
Share-based compensation granted
Denominator for diluted net loss per Ordinary Share - adjusted weighted average number of Ordinary Shares (in Shares)	14,124,404	13,927,788	13,779,885

Related Party Balances and Tr_3

Related Party Balances and Transactions (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Related Party Transactions [Abstract]
Aggregate net amounts of lease and maintenance expenses	$ 830	$ 863	$ 912
Administrative and IT services amount	33	30	49
Aggregate amounts	446	52
Salary expenses	119	112	108
Affiliates amount of related party	$ 121	$ 67	$ 288

Related Party Balances and Tr_4

Related Party Balances and Transactions (Details) - Schedule of balances with related parties - Related Parties [Member] - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Assets:
Other accounts receivable and prepaid	$ 165
Operating lease right-of-use assets	1,303	1,997
Liabilities:
Trade payables	194	76
Other liabilities and accrued expenses	88	49
Operating lease liabilities - current	778	671
Operating lease liabilities – non-current	$ 615	$ 1,352

Related Party Balances and Tr_5

Related Party Balances and Transactions (Details) - Schedule of transactions with related parties - Related Party [Member] - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Expenses (1):
Cost of revenues	[1]	$ 189	$ 215	$ 320
Operating expenses:
Research and development, net		1,083	653	829
Sales and marketing		194	191	172
General and administrative		212	206	211
Capital expenses		$ 29		$ 12
[1]	Including utilities expenses charged to the related party and reimbursed by the Company.

Subsequent Events (Details)

Subsequent Events (Details)	1 Months Ended
	Feb. 28, 2022
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Board approved grants, description	the Company’s Board approved the grant of 298,000 RSUs to certain employees and officers of the Company. Such RSUs have vesting schedules of 2-4 years, commencing as of the date of grant.